283
Participants
Start Date
April 30, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
March 31, 2009
eplivanserin (SR46349)
5 mg/day
lormetazepam
1 mg/day
Sanofi-Aventis Administrative Office, Santiago
Sanofi-Aventis Administrative Office, Tallinn
Sanofi-Aventis Administrative Office, Helsinki
Sanofi-Aventis Administrative Office, Paris
Sanofi-Aventis Administrative Office, Gouda
Sanofi-Aventis Administrative Office, Lysaker
Sanofi-Aventis Administrative Office, Porto Salvo
Sanofi-Aventis Administrative Office, Barcelona
Lead Sponsor
Sanofi
INDUSTRY